Description
Release form
capsules
Packing
28 pcs.
Indications
acute and recovery periods of severe traumatic brain injury and ischemic stroke, recovery period of hemorrhagic stroke occurring with focal hemispheric symptoms or symptoms of damage to the brain stem
psycho-organic syndrome due to degenerative and involutional changes in the brain
chronic cerebrovascular insufficiency
cognitive disorders (impaired mental function, memory, confusion, disorientation, disorientation, ability to concentrate) including dementia and encephalopathy.
senile pseudomelancholy.
Contraindications
Hypersensitivity, pregnancy, breastfeeding.
Special instructions
If you experience nausea after taking the drug, you should reduce the dose.
Cerepro has no effect on the speed of psychomotor reactions.
Composition
1 caps. choline alfoscerate (glycerylphosphorylcholine hydrate) 400 mg.
Excipients:
glycerol (glycerin),
purified water.
Composition of the capsule shell:
medical gelatin,
glycerol (glycerin),
methyl parahydroxybenzoate (methyl paraben),
propyl parahydroxybenzoate (propyl paraben),
iron dye sorbitol sorbl, srdl, srd
Dosage and administration of
In chronic conditions: 0.4 g orally (1 capsule) 3 times a day, preferably before meals.
Duration of treatment is 3-6 months.
Side effects
Allergic reactions, nausea (due to dopaminergic activation).
Storage conditions
Dry, protected from light and inaccessible to children at a temperature of 25 ° C.
active substance
Choline alphosceratus
Conditions of release from drugstores
Prescription
lekarstvennaja form
kapsul
Veropharm, Russia
